Vivo Capital
Edit

Vivo Capital

http://vivocapital.com
Last activity: 20.03.2024
Invests in categories: MedtechDevelopmentProductDrugHealthTechBioTechPlatformTechnologyHardwareResearch
Vivo Capital is a healthcare focused investment firm formed in 1996 that is currently making investments from its $1.4B Vivo Capital Fund IX into promising private healthcare companies and from its $635M Vivo Opportunity Fund into promising public healthcare companies. Vivo’s Three Fund Vehicles Our Team
News
111
Portfolio
167
Mentions
44
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Series A; Series B; Series C; Series D; Series E

Portfolio 167

DateNameWebsiteTotal RaisedLocation
11.02.2024Avistone B...avistonebi...--
07.08.2023Gracell Bi...gracellbio...$250MChina, Jia...
26.06.2023Visirna Th...visirna.co...--
22.03.2023EpiBiologi...epibiologi...$50M-
23.01.2023Pulmocidepulmocide....$174MUnited Kin...
21.11.2022Zenas BioP...zenasbio.c...$118MUnited Sta...
15.11.2022Bonum Ther...bonumtx.co...$93MUnited Sta...
07.07.2022Inspirnainspirna.c...$50MUnited Sta...
28.06.2022Cerebral T...cerebralth...$78MUnited Sta...
06.04.2022PowerVisio...powervisio...$86.5MUnited Sta...
Show more

News 111

DateTitleDescription
04.01.2024Beijing oncology biotech Avistone raises $140M Series B for ...-
04.01.2024Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Ac...-
26.12.2023AstraZeneca to acquire Gracell, furthering cell therapy ambi...-
26.12.2023Bristol Myers Squibb secures RayzeBio in $4.1 billion deal, ...-
28.09.2023Vivo Capital invests in Createrna-
05.09.2023Zenas BioPharma Announces Strategic License and Collaboratio...-
25.07.2023Visirna doses first patient in pivotal study in Chinese adul...-
20.07.2023EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Offi...-
04.07.2023RareStone’s pitolisant (Wakix) was approved by China NMPA fo...-
09.11.2022ScienTech Medical Technology, a Vivo Capital portfolio compa...-
Show more

Mentions in press and media 44

DateTitleDescriptionSource
20.03.2024Startup Lands $150M for Delicate Dance Between Cancer Cells ...Cancer immunotherapy comes in several forms, and one area of growing research interest is a type of ...medcitynew...
07.11.2022Vivo Capital Invests in Zenas Biopharma’s $118 Million Finan...-vivocapita...
08.12.2021Avistone Pharmaceuticals Secures $200M Strategic Investment ...-vivocapita...
08.12.2021Vivo Capital, Leads a $200m Series A Round of Financing in A...-vivocapita...
30.11.2021Vivo Capital, Co-Leads a $75m Series A Round of Financing in...-vivocapita...
19.10.2021Vivo Leads a $32mm Series A Financing in HistoWiz-vivocapita...
27.05.2021Scientia Raises $50M Growth Equity Investment from Vivo Capi...Scientia Vascular (“Scientia” or the “Company”), a rapidly growing commercial company focused on hel...marketscre...
27.05.2021Esco Lifesciences Closes a Record-Setting US$200M Series A R...SINGAPORE, May 27, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company"...en.prnasia...
27.05.2021Esco Lifesciences Closes a Record-Setting US$200M Series A R...SINGAPORE, May 26, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company"...marketscre...
26.05.2021Esco Lifesciences Closes a Record-Setting US$200M Series A R...prnewswire...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In